Biohaven Ltd (NYSE: BHVN) kicked off on Tuesday, up 14.27% from the previous trading day, before settling in for the closing price of $8.27. Over the past 52 weeks, BHVN has traded in a range of $7.48-$47.75.
Healthcare Sector giant saw their annual sales slid by -49.78% over the last five years. While this was happening, its average annual earnings per share was recorded 23.81%. With a float of $93.02 million, this company’s outstanding shares have now reached $105.80 million.
Biohaven Ltd (BHVN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Biohaven Ltd is 12.13%, while institutional ownership is 81.95%. The most recent insider transaction that took place on Nov 17 ’25, was worth 144,770. In this transaction VP, Chief Accounting Officer of this company bought 17,000 shares at a rate of $8.52, taking the stock ownership to the 20,000 shares. Before that another transaction happened on Nov 13 ’25, when Company’s Director bought 400,000 for $7.50, making the entire transaction worth $3,000,000. This insider now owns 2,020,071 shares in total.
Biohaven Ltd (BHVN) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -1.71 earnings per share (EPS), lower than consensus estimate (set at -1.47) by -0.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.99% during the next five years compared to -49.78% drop over the previous five years of trading.
Biohaven Ltd (NYSE: BHVN) Trading Performance Indicators
Take a look at Biohaven Ltd’s (BHVN) current performance indicators. Last quarter, stock had a quick ratio of 2.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.60, a number that is poised to hit -1.45 in the next quarter and is forecasted to reach -3.99 in one year’s time.
Technical Analysis of Biohaven Ltd (BHVN)
Analysing the last 5-days average volume posted by the [Biohaven Ltd, BHVN], we can find that recorded value of 7.27 million was better than the volume posted last year of 2.21 million. As of the previous 9 days, the stock’s Stochastic %D was 45.50%.
During the past 100 days, Biohaven Ltd’s (BHVN) raw stochastic average was set at 17.77%, which indicates a significant increase from 17.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.11 in the past 14 days, which was higher than the 0.96 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.13, while its 200-day Moving Average is $19.20. Now, the first resistance to watch is $10.02. This is followed by the second major resistance level at $10.60. The third major resistance level sits at $11.49. If the price goes on to break the first support level at $8.55, it is likely to go to the next support level at $7.66. Now, if the price goes above the second support level, the third support stands at $7.08.
Biohaven Ltd (NYSE: BHVN) Key Stats
The company with the Market Capitalisation of 1.00 billion has total of 105,855K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -846,420 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -173,440 K.
